Inventor
OHLSTEIN ELIOT
US11 patents
⚠️ This page may combine multiple inventors who share the name “OHLSTEIN ELIOT”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
VELICEPT THERAPEUTICS INC
6 patentsUS9956194B2May 1, 2018
Compositions and methods of using modified release solabegron for lower urinary tract symptoms
VELICEPT THERAPEUTICS INC18 citations89
US10350182B2Jul 16, 2019
Pharmaceutical compositions and the treatment of overactive bladder
VELICEPT THERAPEUTICS INC6 citations81
US9907767B2Mar 6, 2018
Pharmaceutical compositions and the treatment of overactive bladder
VELICEPT THERAPEUTICS INC10 citations81
US9522129B2Dec 20, 2016
Pharmaceutical Combination
VELICEPT THERAPEUTICS INC14 citations81
US10668034B2Jun 2, 2020
Pharmaceutical compositions and the treatment of overactive bladder
VELICEPT THERAPEUTICS INC1 citations70
US10751311B2Aug 25, 2020
Compositions and methods of using modified release solabegron for lower urinary tract symptoms
VELICEPT THERAPEUTICS INC2 citations68
VTV THERAPEUTICS LLC
4 patentsUS9968613B2May 15, 2018
Use of a ppar-delta agonist for reducing loss of muscle strength, muscle mass, or type I muscle fibers in an immobilized limb
VTV THERAPEUTICS LLC12 citations92
US9487493B2Nov 8, 2016
Use of a PPAR-delta agonist for treating muscle atrophy
VTV THERAPEUTICS LLC17 citations92
US10456406B2Oct 29, 2019
Use of a PPAR-δ agonist for reducing loss of muscle strength, muscle mass, or type I muscle fibers in an immobilized limb
VTV THERAPEUTICS LLC9 citations83
US11096946B2Aug 24, 2021
Use of a PPAR-δ agonist for reducing loss of muscle strength, muscle mass, or type I muscle fibers in an immobilized limb
VTV THERAPEUTICS LLC2 citations72